Clovis Oncology, Inc. Research and Development in Process
Clovis Oncology, Inc. reported Research and Development in Process of $9.44 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2021-02-25
- Clovis Oncology, Inc. research and development in process for the quarter ending 2019-12-31 was $0.00.
- Clovis Oncology, Inc. research and development in process for the quarter ending 2019-09-30 was $9.44M.
- Clovis Oncology, Inc. research and development in process for fiscal 2019 was $9.44M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.44M derived: sum of 2 quarters · filed 2021-02-25 | $9.44M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $9.44M 10-Q · filed 2020-11-05 | $9.44M 10-Q · filed 2020-11-05 |